Previous Article | Next Article 
Journal of Virology, February 2005, p. 1613-1622, Vol. 79, No. 3
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.3.1613-1622.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein
Philippe Gripon,1
Isabelle Cannie,1 and
Stephan Urban2*
Institut National de la Santé et de la Recherche Médicale (INSERM) U522, Hôpital de Pontchaillou, Rennes, France,1
Molekulare Virologie, Otto-Meyerhof-Zentrum (OMZ), Universität Heidelberg, Heidelberg, Germany2
Received 7 July 2004/
Accepted 8 October 2004
The lack of an appropriate in vitro infection system for the major human pathogen hepatitis B virus (HBV) has prevented a molecular understanding of the early infection events of HBV. We used the novel HBV-infectible cell line HepaRG and primary human hepatocytes to investigate the interference of infection by HBV envelope protein-derived peptides. We found that a peptide consisting of the authentically myristoylated N-terminal 47 amino acids of the pre-S1 domain of the large viral envelope protein (L protein) specifically prevented HBV infection, with a 50% inhibitory concentration (IC50) of 8 nM. The replacement of myristic acid with other hydrophobic moieties resulted in changes in the inhibitory activity, most notably by a decrease in the IC50 to picomolar concentrations for longer unbranched fatty acids. The obstruction of HepaRG cell susceptibility to HBV infection after short preincubation times with the peptides suggested that the peptides efficiently target and inactivate a receptor at the hepatocyte surface. Our data both shed light on the molecular mechanism of HBV entry into hepatocytes and provide a basis for the development of potent hepadnaviral entry inhibitors as a novel therapeutic concept for the treatment of hepatitis B.
* Corresponding author. Mailing address: Molekulare Virologie, Otto-Meyerhof-Zentrum (OMZ), Universität Heidelberg, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany. Phone: 49-6221-562910. Fax: 49-6221-561946. E-mail:
Stephan_Urban{at}med.uni-heidelberg.de.
In memory of Peter Hans Hofschneider.
Journal of Virology, February 2005, p. 1613-1622, Vol. 79, No. 3
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.3.1613-1622.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Le Duff, Y., Blanchet, M., Sureau, C.
(2009). The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent. J. Virol.
83: 12443-12451
[Abstract]
[Full Text]
-
Lepere-Douard, C., Trotard, M., Le Seyec, J., Gripon, P.
(2009). The First Transmembrane Domain of the Hepatitis B Virus Large Envelope Protein Is Crucial for Infectivity. J. Virol.
83: 11819-11829
[Abstract]
[Full Text]
-
Chai, N., Chang, H. E., Nicolas, E., Han, Z., Jarnik, M., Taylor, J.
(2008). Properties of Subviral Particles of Hepatitis B Virus. J. Virol.
82: 7812-7817
[Abstract]
[Full Text]
-
Gudima, S., He, Y., Chai, N., Bruss, V., Urban, S., Mason, W., Taylor, J.
(2008). Primary Human Hepatocytes Are Susceptible to Infection by Hepatitis Delta Virus Assembled with Envelope Proteins of Woodchuck Hepatitis Virus. J. Virol.
82: 7276-7283
[Abstract]
[Full Text]
-
Abou-Jaoude, G., Sureau, C.
(2007). Entry of Hepatitis Delta Virus Requires the Conserved Cysteine Residues of the Hepatitis B Virus Envelope Protein Antigenic Loop and Is Blocked by Inhibitors of Thiol-Disulfide Exchange. J. Virol.
81: 13057-13066
[Abstract]
[Full Text]
-
Chai, N., Chang, H. E., Nicolas, E., Gudima, S., Chang, J., Taylor, J.
(2007). Assembly of Hepatitis B Virus Envelope Proteins onto a Lentivirus Pseudotype That Infects Primary Human Hepatocytes. J. Virol.
81: 10897-10904
[Abstract]
[Full Text]
-
Blanchet, M., Sureau, C.
(2007). Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues. J. Virol.
81: 5841-5849
[Abstract]
[Full Text]
-
Chai, N., Gudima, S., Chang, J., Taylor, J.
(2007). Immunoadhesins Containing Pre-S Domains of Hepatitis B Virus Large Envelope Protein Are Secreted and Inhibit Virus Infection. J. Virol.
81: 4912-4918
[Abstract]
[Full Text]
-
Gudima, S., Meier, A., Dunbrack, R., Taylor, J., Bruss, V.
(2007). Two Potentially Important Elements of the Hepatitis B Virus Large Envelope Protein Are Dispensable for the Infectivity of Hepatitis Delta Virus. J. Virol.
81: 4343-4347
[Abstract]
[Full Text]
-
Blanchet, M., Sureau, C.
(2006). Analysis of the Cytosolic Domains of the Hepatitis B Virus Envelope Proteins for Their Function in Viral Particle Assembly and Infectivity. J. Virol.
80: 11935-11945
[Abstract]
[Full Text]
-
Zhang, P., Yu, M.-y. W., Venable, R., Alter, H. J., Shih, J. W.-K.
(2006). Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees. Proc. Natl. Acad. Sci. USA
103: 9214-9219
[Abstract]
[Full Text]
-
Jaoude, G. A., Sureau, C.
(2005). Role of the Antigenic Loop of the Hepatitis B Virus Envelope Proteins in Infectivity of Hepatitis Delta Virus. J. Virol.
79: 10460-10466
[Abstract]
[Full Text]
-
Barrera, A., Guerra, B., Notvall, L., Lanford, R. E.
(2005). Mapping of the Hepatitis B Virus Pre-S1 Domain Involved in Receptor Recognition. J. Virol.
79: 9786-9798
[Abstract]
[Full Text]